Cardiac disease is a major cause of mortality in Duchenne muscular dystrophy (DMD), yet data regarding outcomes and cardiac disease progression are lacking. This has led to a highly variable approach to heart failure therapy in DMD from center to center, according to a new report that surveyed pediatric cardiologists within the Advanced Cardiac Therapies Improving Outcomes Network (ACTION), a multicenter heart failure quality improvement network.

Read more at Pediatrics Nationwide: Variability in Cardiac Diagnostics and Therapies for Patients with Duchenne Muscular Dystrophy.